ClinicalTrials.Veeva

Menu

Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer

M

Mansoura University

Status

Unknown

Conditions

Recurrence

Treatments

Procedure: Lymph node harvesting

Study type

Observational

Funder types

Other

Identifiers

NCT05221684
LN ratio in rectal cancer

Details and patient eligibility

About

This study aims to evaluate the value of the LNR as a prognostic indicator in patients with rectal cancer who offered total mesorectal excision.

Full description

Patients and methods Study design and setting This is a retrospective review of prospectively collected and maintained database of patients with CRC admitted in the Oncology Center of Mansoura University (OCMU), the Colorectal Surgery Unit of Mansoura University Hospitals, and the Department of General Surgery of Alexandria University.

Selection criteria Patients of either gender aged 18 years or above who presented with rectal cancer of any stage will be included in the study. We will exclude patients with patients younger than 18 years; patients with synchronous colon cancer; synchronous liver, pulmonary or bones metastasis; or synchronous gastrointestinal cancer; or patients who were lost to follow-up.

Study endpoints The primary endpoint of the study is to assess the value of lymph node ratio (LNR) on the oncological outcomes.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • rectal cancer of TNM stage I-III
  • underwent radical resection with curative intent

Exclusion criteria

  • synchronous colon cancer
  • synchronous gastrointestinal cancer
  • underwent palliative resection
  • presented with intestinal obstruction
  • those lost to follow-up.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems